Feosol

Quick links to important sections

Feosol

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Feosol

What is Feosol?

Feosol is an over-the-counter (OTC) dietary supplement used to treat or prevent iron-deficiency anemia. It provides the body with supplemental iron, an essential mineral necessary for the production of red blood cells and the proper functioning of hemoglobin, the protein responsible for transporting oxygen throughout the body. A deficiency in iron can lead to fatigue, weakness, and other symptoms associated with anemia.


Quick Facts

  • Primary Use: Treatment and prevention of iron-deficiency anemia.
  • Active Ingredient: Contains various forms of iron, commonly ferrous sulfate, ferrous gluconate, or ferrous fumarate.
  • Classification: Dietary supplement (mineral).
  • Availability: Available OTC in capsule or tablet form.

Feosol products utilize different iron salts, which influence how the iron is absorbed and tolerated by the user. For instance, the active ingredient in many Feosol products is ferrous sulfate, a form of iron that is readily absorbed and commonly used to replenish iron stores. Other formulations may use less common salts. While Feosol is effective for increasing iron levels, it is typically recommended that it be taken only after consulting with a healthcare professional to confirm an iron deficiency and to receive guidance on appropriate dosage.

Regulatory References

  1. NIH Iron Deficiency Anemia
  2. MedlinePlus Iron in Diet
  3. NIH Iron Recommended Dietary Allowances

What side effects are possible with Feosol?

Possible Side Effects and Safety Information: Feosol

Official government regulatory documentation organizes the safety profile of Feosol (ferrous sulfate) based on common adverse reactions, critical risks, and specific cautions regarding use and co-administration with other medicines.

Adverse Reaction Scope

Category Documented Information
Key Adverse Reaction Categories Gastrointestinal disturbances are the most common adverse reactions.
Frequency Classification Common adverse reactions include stomach pain or discomfort, nausea, vomiting, constipation, and diarrhea.
System-Organ Classes Involved Gastrointestinal system.
Serious Adverse Reactions Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six years of age.
Population-Specific Safety Considerations This product carries a specific, critical warning regarding the toxicity risk for the pediatric population; caution is advised for patients with active enteritis, colitis, or peptic ulcer.
Dose- or Exposure-Related Patterns Blackening or darkening of the stool is a documented, expected occurrence due to unabsorbed iron and is not typically a cause for concern.
Safety-Related Restrictions or Limitations Iron products can interfere with the absorption of certain oral medications, such as some antibiotics (e.g., tetracycline), and should not be taken within two hours of each other.

Regulatory Safety Structure

The regulatory safety profile highlights that while common side effects are generally confined to the gastrointestinal system, the principal concern is the serious toxicity risk in the event of accidental pediatric ingestion. Furthermore, the official safety documentation includes a defined restriction regarding drug-drug interactions to minimize absorption interference with certain co-administered oral medications.

Overdose and Emergency Response

Overdose and When to Seek Help

Accidental overdose of iron-containing products is explicitly documented in regulatory information as a leading cause of fatal poisoning in children younger than 6 years of age. For this reason, these products must be kept out of the reach of children.

Documented Overdose Presentations

Symptoms of a severe overdose, which is classified as potentially fatal, may involve multiple body systems. The documented clinical manifestations of overdose include:

  • Severe gastrointestinal distress, such as very upset stomach, very bad belly pain, bloody diarrhea, coughing up blood, black or tarry stools, and vomiting blood or vomit that resembles coffee grounds.
  • Systemic effects like pale skin, blue lips, shallow breathing, and a weak and rapid pulse.
  • Neurological events, specifically seizure (convulsions).

Required Emergency Action

Official regulatory documents emphasize that in case of a suspected or accidental overdose, it is essential to seek immediate medical care. If you think there has been an overdose, you must call a doctor or Poison Control Center right away, even if symptoms have not yet appeared or are not severe. The high-risk population for fatal outcomes is children under the age of 6, for whom accidental overdose is explicitly noted as a severe, life-threatening emergency requiring prompt attention.

Therapeutic Uses of Feosol

Quick Facts

  • Primary Purpose: To address and prevent conditions associated with low levels of iron.
  • Key Therapeutic Domain: Supports the management of iron-deficiency anemia.
  • Supports: The body's processes for forming red blood cells.

What Feosol Supports: Uses and Benefits

Feosol, which contains an iron salt (ferrous sulfate or other forms of iron), is generally utilized as a dietary iron supplement. The principal use of this product is to help prevent or assist in the treatment of iron-deficient states within the body. These states may be caused by an inadequate dietary intake of iron, chronic blood loss, or physiological requirements, such as during pregnancy.

Replenishing iron stores is necessary for the proper function of the body's processes, particularly the production of red blood cells. Maintaining appropriate iron levels contributes to the delivery of oxygen by the blood to various tissues and organs. The utilization of an iron supplement such as Feosol is an established strategy for managing the signs and related outcomes of iron-deficiency anemia, including the presentation of physical tiredness and diminished physical capacity.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Feosol (Ferrous Sulfate)

Official regulatory guidelines strictly define the populations that can and cannot use Feosol, an iron supplement (ferrous sulfate), based on risk of iron overload and specific health conditions.


Populations Who Must Not Use Feosol (Contraindications)

Feosol is contraindicated and must not be used by individuals with documented conditions of iron overload, such as hemosiderosis or primary hemochromatosis. Use is also prohibited for patients receiving repeated blood transfusions and those with certain active gastrointestinal conditions, including active peptic ulceration or ulcerative colitis.

Populations Requiring Restricted or Conditional Use

Use of Feosol is restricted or requires professional guidance for several groups:

  • Anemia Type: Individuals with anemias not produced by iron deficiency (e.g., hemolytic anemia) should not use this supplement unless a coexisting iron deficiency is confirmed.
  • Gastrointestinal Health: Patients with existing GI conditions like inflammatory bowel disease or intestinal strictures require cautious use and medical supervision.
  • Age and Pediatric Risk: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six. The product must be stored out of their reach. Children under the age of 12 must consult a physician before use.
  • Reproductive Status: Pregnant or nursing individuals must seek the advice of a health professional prior to using Feosol.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Feosol (ferrous sulfate) is primarily defined by the ability of iron, a polyvalent cation, to chelate (bind) with other substances in the gastrointestinal tract, significantly reducing the absorption of both the iron and the co-administered agent.


Clinically Significant Drug Interactions

To maintain the effectiveness of both medications, the regulatory label requires time separation between the administration of Feosol and the following drug categories:

Interacting Product Category Example Medicines Required Action
Quinolone Antibiotics Ciprofloxacin, Levofloxacin Separate by at least 2 to 6 hours.
Tetracycline Antibiotics Doxycycline, Minocycline Separate by at least 2 to 3 hours.
Thyroid Agents Levothyroxine Separate doses by at least 2 hours.
Other Drugs Levodopa, Penicillamine, HIV integrase inhibitors Time separation required to avoid reduced efficacy.

Interactions Affecting Feosol Absorption

The absorption of Feosol itself may be reduced by products that decrease stomach acidity or by specific dietary components. Antacids and acid- reducing medicines (such as PPIs and H2 blockers) must be separated from Feosol by at least two hours. Similarly, the absorption of iron is significantly reduced by foods containing high levels of phytates, tannins, or calcium, including cereals, dairy, tea, and coffee. Vitamin C ( Ascorbic Acid), however, is known to enhance iron absorption.

Restrictions

Feosol must not be used concomitantly with other oral or parenteral iron products due to the risk of iron overload. The efficacy of iron-chelating agents, such as Deferiprone, may be affected by co-administration.

Mechanism of Action

How Feosol Works

Feosol delivers elemental iron (ferrous Fe^2+), functioning as a substrate across three core mechanistic domains.


Iron Absorption and Plasma Transport

This mechanism begins in the digestive tract where iron is taken up by the Divalent Metal Transporter 1 (DMT1) on the duodenal enterocytes. Once absorbed, the iron immediately binds to the transport protein transferrin in the plasma. This process facilitates the supply of raw material, which is necessary for contributing to the total pool of functional iron in the body.


Supporting Hemoglobin Synthesis

The iron is then directed to the bone marrow where it acts as a required cofactor for the synthesis of the heme group of hemoglobin. The support of the Hemoglobin Synthesis Pathway increases the rate of hemoglobin formation. This supports the development of the blood's systemic oxygen-carrying capacity.


Enabling Cellular Metabolism

This domain involves the incorporation of iron into cytochromes within the mitochondria, which are crucial components of the Electron Transport Chain and metabolic pathways for ATP synthesis. Ensuring the function of these iron-dependent enzymes contributes to the activity of core cellular processes necessary for fundamental cellular function and metabolic regulation.

Dosage and Administration Information

How to Use Feosol

Feosol, primarily containing ferrous sulfate, is an oral iron supplement administered solely by the oral route as tablets, caplets, or liquid solutions. The dosage is typically based on the amount of elemental iron provided, with the standard unit dose often containing 65 mg.

For general iron supplementation or prophylaxis, the product is typically used once daily. For the therapeutic treatment of established iron-deficiency anemia, the official regimen may require higher doses, administered in divided doses up to three times per day.


Administration Timing and Constraints

Aspect Official Usage Principle
Timing with Meals Absorption is maximized when taken on an empty stomach (e.g., one hour before a meal), but may be taken with food to minimize potential discomfort.
Preparation Tablets must be swallowed whole with water and should not be crushed, chewed, or sucked, as this can affect the intended release and cause mucosal injury.
Separation Intake should be separated by at least two hours from known inhibitors like tea, coffee, milk, and certain medications (e.g., antacids or some antibiotics) to ensure proper absorption.
Duration The course of use is generally long-term, extending for several months (often 3 to 6 months) after the body’s iron levels have normalized to fully replenish stored iron.

The official usage protocol defines age limits, with the standard adult dosing applicable to children 12 years of age and older, while dosing for younger children must be determined and supervised by a health professional. If a dose is missed, it should be taken as soon as it is remembered, unless it is close to the next scheduled dose, in which case the missed dose is skipped to prevent taking a double amount.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Drug Activity Studies

Studies have been conducted to understand the drug's activity. The drug was evaluated for its effects in models of inflammation. The active ingredient in Feosol is ferrous sulfate, a common form of iron supplementation.


Evaluations of Single-Agent Use

Clinical investigations have focused on evaluating the role of ferrous sulfate in managing iron-deficiency anemia (IDA), which is defined by low hemoglobin levels and depleted iron stores. A primary investigation involving 500 participants examined the effects of the drug on markers such as serum ferritin and hemoglobin levels. The investigation recorded observations related to these key blood indices over the study period.

Further analysis reviewed the drug’s use in chronic manifestations of iron depletion. The evidence collected relates to individuals with moderate-to-severe deficiencies requiring oral repletion therapy.


Combination Therapy Research

Research has evaluated whether combination therapy with iron-absorption enhancers, such as vitamin C, is associated with a change in iron bioavailability and long-term repletion outcomes compared to iron monotherapy.


Use in Specific Populations

Clinical trials have included pregnant individuals and children, evaluating the effectiveness and tolerance of ferrous sulfate in preventing and treating IDA within these groups. Research has informed the context for using the drug in individuals with pre-existing gastrointestinal conditions, given the potential for common side effects like constipation or nausea. The findings from these studies contribute to the established evidence base related to iron status management and the prevention of deficiency-related symptoms.

Key Studies & References

  1. Oral iron supplementation for iron deficiency anemia in adults: a systematic review and meta-analysis
  2. NICE Guideline NG131: Iron deficiency anaemia in children and young people

Frequently Asked Questions (FAQ)

Common questions about Feosol (FAQ)


Q: What is the primary medical reason people take Feosol?

A: The active ingredient in Feosol is ferrous sulfate, which is officially indicated for the treatment or prevention of low blood levels of iron. According to official product information, this is often used when a person has an iron deficiency or a resulting condition known as iron deficiency anemia. The product is designed to provide elemental iron, which is necessary for the body's iron stores and functional iron pool.


Q: Is Feosol appropriate for use during pregnancy or while breastfeeding?

A: Standard patient information advises consulting a healthcare professional before using the product during pregnancy or while nursing. Iron supplementation is often recommended by physicians for individuals with increased iron needs, which commonly occurs during these life stages. The decision to use iron during these life stages must be made in consultation with a healthcare professional.


Q: Is Feosol safe to use if I have a history of ulcers?

A: Regulatory warnings advise consulting a healthcare professional before use if you have a history of stomach or intestinal problems, such as ulcers, colitis, or regional enteritis. This is because iron supplements can potentially cause or worsen gastrointestinal irritation. Guidance on use, especially with a history of ulcers, requires consultation with a healthcare professional.


Q: Why is Feosol sometimes recommended for individuals with heavy menstrual bleeding?

A: The use of iron supplementation is related to the fact that blood loss can be a direct cause of iron deficiency. Health authorities note that heavy menstrual periods are a known and common source of chronic blood loss, which can deplete the body's iron stores and lead to low iron levels.


Q: What is the difference between iron deficiency and anemia?

A: This question addresses a clarification often found in patient educational materials. Iron deficiency is the condition that occurs when the body's iron stores are insufficient. Iron deficiency anemia is the clinical condition that results from this deficiency, where the body is unable to produce enough healthy red blood cells due to the lack of iron.


Q: Is Feosol a prescription medicine or over-the-counter?

A: Ferrous sulfate products, including brand names like Feosol, are typically classified by the FDA as an Over-the-Counter (OTC) drug or a Dietary Supplement. This means the product is widely available for purchase without requiring a prescription.


Q: Is Feosol considered a 'drug' or a 'dietary supplement'?

A: Depending on the specific product formulation and how it is registered with the regulatory bodies, ferrous sulfate can be classified as either a Human OTC Drug or a Dietary Supplement. Both classifications require the product to meet specific standards for quality and labeling.


Q: Is it possible to take too much Feosol?

A: Yes. Official warnings emphasize the serious risk of iron overdose, particularly in young children, and caution against taking more than the amount suggested on the label. Accidental overdose of products containing iron is a leading cause of fatal poisoning in young children.


Q: What are the main risks associated with high iron levels?

A: Product warnings advise against using iron supplements if a person has an iron overload syndrome, such as hemochromatosis. Excessively high levels of iron can potentially accumulate and cause damage to vital organs like the liver, heart, and pancreas.


Q: Why is it important to keep Feosol out of reach of children?

A: Product labeling contains a prominent warning emphasizing that accidental overdose of iron-containing products is cited as a leading cause of fatal poisoning in children younger than 6 years of age. Due to this serious risk, regulatory labels include a prominent warning to keep the product out of the reach of children.


Q: Does taking Vitamin C help with Feosol?

A: Information provided by health authorities notes that Vitamin C (ascorbic acid) may help increase the body's absorption of iron. Some formulations of iron supplements may combine the two ingredients for this reason.


Q: Is a metallic taste in the mouth an expected side effect of Feosol?

A: Yes, some common side effects that are reported with the use of iron supplementation include gastrointestinal issues, constipation, and a metallic taste in the mouth. These effects are sometimes observed to subside over time.


Q: Are there specific instructions for storing Feosol?

A: Official storage instructions recommend keeping the product at controlled room temperature (generally between 15 C and 30 C or 59 F and 86 F). It should also be stored in a dry place, securely away from moisture and heat.


Q: Can Feosol interfere with routine lab tests?

A: Official information indicates there is a potential for iron supplements to interfere with the results of certain laboratory tests. Patient information notes the importance of informing laboratory personnel and healthcare providers that an iron supplement is being used.


Q: Can Feosol cause changes in urine color?

A: While the most frequently cited color change is dark or black stools, some patient information notes that changes to body fluids are possible. This may include the potential for dark or discolored urine.


Q: Are there different strengths or formulations of Feosol?

A: Yes, products containing the active ingredient ferrous sulfate are available in multiple formulations. These often include standard immediate-release tablets, delayed-release (enteric-coated) tablets, and sometimes liquid oral solutions.


Q: What is the purpose of the enteric coating on some Feosol pills?

A: Enteric-coated or delayed-release formulations are designed to help the tablet bypass the stomach intact and dissolve later in the small intestine. The design of the coating aims to reduce the possibility of stomach upset or irritation by delaying the release of iron.


Q: Does Feosol contain sugar or artificial sweeteners?

A: The inactive ingredients vary across different product forms. Specific liquid formulations of ferrous sulfate often contain sucrose (sugar). Tablet and capsule formulations may also contain various inactive ingredients, including sweeteners, based on the specific product's labeling.

How should Feosol be stored and disposed of?

How to Store and Dispose of Feosol (Ferrous Sulfate)

Storage and disposal requirements for Feosol are established by regulatory agencies to maintain product stability and ensure safety.

Official Storage Requirements

Storage Component Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Keep the container tightly closed in a dry place. Protect from excessive heat, cold, and moisture.
Child Safety Keep out of the sight and reach of children. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in young children.

Disposal Instructions

Expired or unused Feosol must not be disposed of by flushing down the toilet or pouring down a drain unless specifically instructed by a government authority. Do not place in household trash. To dispose of medicine no longer needed, consult your pharmacist or local drug take-back program for environmentally responsible disposal methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Feosol found in:

A-Z Index: